A novel approach to the discovery of survival biomarkers in glioblastoma using a joint analysis of DNA methylation and gene expression

Metabolic Targeting of Lactate Efflux by Malignant Glioma Inhibits Invasiveness and Induces Necrosis: An In Vivo Study

(2015) Chaim B Colen et al.   NEOPLASIA

Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme

(2013) Moritz C Oberstadt et al.   BMC CANCER

MicroRNA-26a Regulates Pathological and Physiological Angiogenesis by Targeting BMP/SMAD1 Signaling

(2013) Basak Icli et al.   CIRCULATION RESEARCH

Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology

(2013) C. Ferte et al.   CLINICAL CANCER RESEARCH

The SLC16 gene family – Structure, role and regulation in health and disease

(2013) Andrew P. Halestrap   MOLECULAR ASPECTS OF MEDICINE

The integrated landscape of driver genomic alterations in glioblastoma

(2013) Veronique Frattini et al.   NATURE GENETICS

Aquaporin water channels in the nervous system

(2013) Marios C. Papadopoulos et al.   NATURE REVIEWS NEUROSCIENCE

STAT3 silencing inhibits glioma single cell infiltration and tumor growth

(2013) M. Priester et al.   NEURO-ONCOLOGY

Integrative analysis of tissue-specific methylation and alternative splicing identifies conserved transcription factor binding motifs

(2013) J. Wan et al.   NUCLEIC ACIDS RESEARCH

CD105 (Endoglin) exerts prognostic effects via its role in the microvascular niche of paediatric high grade glioma

(2012) Stuart J. Smith et al.   ACTA NEUROPATHOLOGICA

Rab21 attenuates EGF-mediated MAPK signaling through enhancing EGFR internalization and degradation

(2012) Xi Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data

(2012) Wenting Wang et al.   BIOINFORMATICS

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

(2012) Consolación Melguizo et al.   Journal of Translational Medicine

The disturbed blood–brain barrier in human glioblastoma

(2012) Hartwig Wolburg et al.   MOLECULAR ASPECTS OF MEDICINE

Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets

(2012) Vera Miranda-Gonçalves et al.   NEURO-ONCOLOGY

DNA methylation in glioblastoma: impact on gene expression and clinical outcome.

(2011) Amandine Etcheverry et al.   BMC GENOMICS

The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma

(2011) Gulsah Cecener et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Transmembrane protein 2 (Tmem2) is required to regionally restrict atrioventricular canal boundary and endocardial cushion development

(2011) K. A. Smith et al.   DEVELOPMENT

The novel transmembrane protein Tmem2 is essential for coordination of myocardial and endocardial morphogenesis

(2011) R. Totong et al.   DEVELOPMENT

Causal Mediation Analysis With Survival Data

(2011) Tyler J. VanderWeele   EPIDEMIOLOGY

DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression

(2011) Shichun Zheng et al.   NEURO-ONCOLOGY

DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer

(2011) P Lopez-Serra et al.   ONCOGENE

Phosphoproteomic Analysis Identifies Grb10 as an mTORC1 Substrate That Negatively Regulates Insulin Signaling

(2011) Y. Yu et al.   SCIENCE

Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma

(2010) Houtan Noushmehr et al.   CANCER CELL

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Aquaporin and Blood Brain Barrier

(2010) Bonomini Francesca et al.   Current Neuropharmacology

NF-κB and STAT3 signaling in glioma: targets for future therapies

(2010) George P Atkinson et al.   Expert Review of Neurotherapeutics

MicroRNA 320a Functions as a Novel Endogenous Modulator of Aquaporins 1 and 4 as Well as a Potential Therapeutic Target in Cerebral Ischemia

(2010) Sugunavathi Sepramaniam et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma

(2010) Brock C. Christensen et al.   JNCI-Journal of the National Cancer Institute

Reciprocal imprinting of human GRB10 in placental trophoblast and brain: evolutionary conservation of reversed allelic expression

(2009) David Monk et al.   HUMAN MOLECULAR GENETICS

Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network

(2009) Michael Weller et al.   JOURNAL OF CLINICAL ONCOLOGY

A survey of glioblastoma genomic amplifications and deletions

(2009) Shailaja K. Rao et al.   JOURNAL OF NEURO-ONCOLOGY

Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array

(2009) Helena Nord et al.   NEURO-ONCOLOGY

DNA hypomethylation in cancer cells

(2009) Melanie Ehrlich   Epigenomics

Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions

(2008) E Andres Houseman et al.   BMC BIOINFORMATICS

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

(2008) Roger McLendon et al.   NATURE

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE